AstraZeneca PLC - Total Debt To Ebitda

AstraZeneca PLC's Fiscal Year is From January To December.

The item "Total-Debt-To-Ebitda" stands at 2.15 as of 09/30/2025.

As of the end of AstraZeneca PLC's third quarter, the item "Total Debt To Ebitda" stands at 2.15. This represents a decrease of -7.13 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 9.40 percent compared to the value the year prior.
The 1 year change in percent is 9.40.
The 3 year change in percent is -37.38.

The Serie's long term average value is 2.60. It's latest available value, on 09/30/2025, is 17.31 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2024, to it's latest available value, on 09/30/2025, is +26.82%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is -50.32%.